FDA proposes mammogram guideline changes for the first time in decades
For the first time in two decades, the U.S. Food and Drug Administration (FDA) proposed an update to its national mammogram regulations in an effort to modernize breast cancer screenings for women — especially for those with dense breasts.
Read More: https://ift.tt/2WAvuyt